Press Releases | Medtronic

Month Year

Email alerts

Apr 9, 2010

Medtronic Hydrodebrider(TM) System Wins Medical Device Excellence Award

Hydrodebrider System Offers Innovative Treatment for Chronic Sinusitis

MINNEAPOLIS, Apr 09, 2010 (BUSINESS WIRE) --Medtronic (NYSE: MDT) announced today that the company was named a 2010 Medical Device Excellence Award (MDEA) winner for excellence in medical device...
Apr 8, 2010

Medtronic Receives 2010 Beacon Council Award for Outstanding Contributions in Life Sciences

MINNEAPOLIS, Apr 08, 2010 (BUSINESS WIRE) --Medtronic, Inc., (NYSE:MDT) received yesterday a Beacon Award from The Beacon Council, Miami-Dade County's official economic development organization,...
Apr 7, 2010

Medtronic Launches New Frontal Handpiece for Its Hydrodebrider(TM) System

Hydrodebrider System Offers Innovative Treatment for Chronic Sinusitis that Affects Nearly 30 Million US Adults1

MINNEAPOLIS, Apr 07, 2010 (BUSINESS WIRE) --Medtronic (NYSE: MDT) announced today the launch of a new Frontal Handpiece for its Hydrodebrider(TM) System, manufactured by the company's Ear Nose and...
Apr 1, 2010

Medtronic Commends U.S. Congress and President for Including National Pain Care Policy Act in Healthcare Reform Legislation to Address Barriers to and Solutions for Effective Pain Management

Company Teams with Physician and Patient Communities to Pass the National Pain Care Policy Act of 2009

MINNEAPOLIS, Apr 01, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT) commended the U.S. Congress and President for signing H.R. 3590, the Patient Protection and Affordable Care Act legislation...
Apr 1, 2010

Medtronic to Appeal Jury Verdict in U.S. Patent Case Involving CoreValve(R) Transcatheter Aortic Valve System

MINNEAPOLIS, Apr 01, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT), announced today that it will appeal the $73.5 million jury verdict returned in the U.S. District Court in Delaware deciding...
Mar 29, 2010

Medtronic and AGA Medical Settle Patent Dispute

MINNEAPOLIS, Mar 29, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT), today announced the settlement of a lawsuit it initiated against AGA Medical Corp. in 2007 for infringement of Medtronic's...
Mar 29, 2010

Newly Published Data Show Medtronic InterStim(R) Therapy Decreases Episodes of Chronic Fecal Incontinence and Positively Impacts Quality of Life

InterStim Therapy for Bowel Control Currently Under Review by the U.S. FDA

MINNEAPOLIS, Mar 29, 2010 (BUSINESS WIRE) --Data published in the March issue of the Annals of Surgery show that investigational use of sacral nerve stimulation with Medtronic InterStim(R) Therapy...
Mar 23, 2010

First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity

Spasticity Affects a Significant Number of Post-Stroke Patients, [1],[2],[3] and Many are not Adequately Treated by Standard Therapy [4] Medtronic, Inc. (NYSE: MDT) today announced the enrollment...
Mar 19, 2010

Medtronic Receives FDA Panel's Unanimous Recommendation for Approval of Revo MRI(TM) SureScan(TM) Pacing System

Positive Step Toward the First Pacemaker System Approval in the United States for Use in the MRI Environment

MINNEAPOLIS, Mar 19, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices...
Mar 18, 2010

First Publication of Data from Pivotal Clinical Trial for Medtronic Deep Brain Stimulation Therapy for Epilepsy Published Today in Epilepsia

MINNEAPOLIS, Mar 18, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that a landmark publication highlighting results from the pivotal study for Medtronic Deep Brain Stimulation...
Mar 17, 2010

Medtronic Receives FDA Approval for Industry's Most Advanced Integrated System for Diabetes Management

Next Generation Integrated System - MiniMed Paradigm(R) REAL-Time Revel(TM) System - Incorporates Predictive Alerts to Help Patients More Tightly Control Diabetes

MINNEAPOLIS, Mar 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm(R) REAL-Time...
Mar 17, 2010

Medtronic Announces Next-Generation Pacing System for Use in MRI Machines Now Commercially Available in Selected European Geographies

Advisa DR MRI(TM) SureScan(TM) Represents the Most Advanced Pacing System from Medtronic that Combines MRI Compatibility with Exclusive Pacing Technology

MINNEAPOLIS, Mar 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today the commercial availability of the Advisa DR MRI(TM) SureScan(TM) pacemaker in selected European...
Mar 17, 2010

Medtronic Completes Pre-Market Approval Submission to FDA for Arctic Front(R) Cardiac CryoAblation Catheter System

MINNEAPOLIS, Mar 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it has completed Pre-Market Approval (PMA) submission in consideration for U.S. Food and Drug...
Mar 16, 2010

Medtronic Introduces "Every Patient First" Initiative to Address Disparities in Access to Health Care

Partnerships with American College of Cardiology and Association of Black Cardiologists and Latest Data from IMPROVE HF Clinical Study All Aim to Drive Equitable Treatment

MINNEAPOLIS & ATLANTA, Mar 16, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today introduced Every Patient First, a health equity initiative that, in partnership with health care providers,...
Mar 15, 2010

Medtronic CareLink(R) Network Remote Monitoring Significantly Reduced Time to Clinical Decision

Late Breaking Clinical Trial at 59th Annual Scientific Session of the American College of Cardiology (ACC) also Showed Shortened Cardiovascular Hospital Stays

MINNEAPOLIS & ATLANTA, Mar 15, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced results from the CONNECT trial showing the median time to clinical decision was significantly...
Mar 15, 2010

Medtronic Announces Initial Results of STOP AF Clinical Trial

Safety and Effectiveness Trial Evaluated the Arctic Front(R) Cardiac CryoAblation Catheter System for the Treatment of Paroxysmal Atrial Fibrillation

MINNEAPOLIS & ATLANTA, Mar 15, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced data from the STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial...
Mar 14, 2010

Medtronic's Endeavor Stent Continues to Demonstrate Compelling and Consistent Long-Term Clinical Results

Independent Analysis of Large and Comprehensive ENDEAVOR Program Shows Remarkably Durable Safety and Efficacy at Five Years of Follow Up in Coronary Artery Disease Patients

MINNEAPOLIS & ALTANTA, Mar 14, 2010 (BUSINESS WIRE) -- The consistency and quality of the long-term clinical results for the Endeavor(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT),...
Mar 12, 2010

Medtronic Starts International Study of CoreValve(R) Transcatheter Aortic Valve System

Post-Market Evaluation of Breakthrough Medical Device Begins Enrolling Patients; First Implants Occur in Germany

MINNEAPOLIS, Mar 12, 2010 (BUSINESS WIRE) -- Moving to expand the evidence base for the future of structural heart disease therapy,Medtronic, Inc. (NYSE: MDT), today announced the start of the...
Mar 12, 2010

FDA Panel Recommends Approval with Conditions of Medtronic Deep Brain Stimulation Therapy for Patients with Refractory Epilepsy

MINNEAPOLIS, Mar 12, 2010 (BUSINESS WIRE) -- The U.S. Food and Drug Administration (FDA) Neurological Devices Panel today voted seven to five to recommend approval with conditions of Deep Brain...
Mar 11, 2010

Medtronic Announces Public Offering of Senior Notes

MINNEAPOLIS, Mar 11, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced a registered offering of $1.25 billion of its 3.0 percent Senior Notes due 2015, $1.25 billion of its 4.45...
Mar 10, 2010

Medtronic Introduces the VERTEX SELECT(R) Reconstruction System

Offering Surgeons the Next Generation of Occipitocervical Upper-Thoracic Fixation

MEMPHIS, Tenn., Mar 10, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of the VERTEX SELECT(R) Reconstruction System. When a patient has a spinal condition...
Mar 9, 2010

William A. Hawkins, Medtronic Chairman and CEO, Receives Distinguished Achievement Award from Biomedical Engineering Society

Lecture Published by Annals of Biomedical Engineering

MINNEAPOLIS, Mar 09, 2010 (BUSINESS WIRE) -- Medtronic, Inc., (NYSE: MDT), today announced William A. Hawkins, chairman and CEO, recently received the Biomedical Engineering Society's...
Mar 4, 2010

Medtronic Named Among World's Most Innovative Companies by MIT Technology Review

Company Recognized for Ground-Breaking Work in the Field of Deep Brain Stimulation Medtronic, Inc. (NYSE: MDT) today announced that it has been selected as one of Massachusetts Institute of Technology
Mar 3, 2010

Medtronic Recognized for Excellence in Corporate Citizenship

Corporate Responsibility Magazine lists Medtronic among 2010's 100 Best Corporate Citizens

NEW YORK, Mar 03, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) was named today to the 11th annual "100 Best Corporate Citizens List" published by Corporate Responsibility magazine (formerly...
Mar 2, 2010

Medtronic CFO Gary Ellis to Speak at the Cowen & Company Health Care Conference

MINNEAPOLIS, Mar 02, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), today announced it will participate in the 30th Annual Cowen and Company Health Care Conference on Tuesday, March 9, 2010,...

Show per page